Lung cancer cannot be cured by taking Kemena eketinib hydrochloride tablets. Eketinib Hydrochloride Tablets is a kind of EGFR gene mutation-targeted drug, which is mainly used for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. Patients with advanced lung cancer can take Ectinib Hydrochloride Tablets orally under the guidance of specialized doctors for targeted therapy to improve the quality of life and prolong the survival time, but it cannot cure advanced lung cancer. Most of the patients with advanced lung cancer have lost the best chance of surgery, but they can choose palliative radiotherapy, targeted drug therapy, immunotherapy and other modalities under the guidance of specialists with the aim of relieving patients’ clinical symptoms and improving the quality of life. Eketinib hydrochloride tablets is a kind of targeted drug therapy, which needs to be applied under the guidance of specialists, and should not be used or stopped without authorization.